ReviewMedicinal chemistry (Shariqah (United Arab Emirates))2025

Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia.

Sarah Gado et al.PubMed ↗Publisher ↗

No numbers read from the abstract.